APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Autoimmune Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Autoimmune Drugs Industry Growth and Trends Forecast to 2032

20 December 202597 pages

Choose your research edition.

Industry ResearchAutoimmune Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Autoimmune Drugs Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Autoimmune Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autoimmune Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Autoimmune Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Autoimmune Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Autoimmune Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Autoimmune Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Autoimmune Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Autoimmune Drugs include Biogen, AbbVie, Amgen, Baxter, GSK, Pfizer, Eli Lilly, Roche and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Autoimmune Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Autoimmune Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Autoimmune Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Autoimmune Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Autoimmune Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Autoimmune Drugs Market by Company

Biogen

AbbVie

Amgen

Baxter

GSK

Pfizer

Eli Lilly

Roche

Johnson & Johnson

Autoimmune Drugs Segment by Type

Psoriasis

Inflammatory Bowel Disease (IBD)

Systemic Lupus Erythematosus (SLE)

Ankylosing Spondylitis (AS)

Rheumatoid Arthritis (RA)

Multiple Sclerosis (MS)

Autoimmune Drugs Segment by Application

Hospitals

Homecare

Specialty Clinics

Autoimmune Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmune Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autoimmune Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmune Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Autoimmune Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Autoimmune Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Psoriasis Table 2. Major Company of Inflammatory Bowel Disease (IBD) Table 3. Major Company of Systemic Lupus Erythematosus (SLE) Table 4. Major Company of Ankylosing Spondylitis (AS) Table 5. Major Company of Rheumatoid Arthritis (RA) Table 6. Major Company of Multiple Sclerosis (MS) Table 7. Global Autoimmune Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Autoimmune Drugs Sales by Type (2021-2026) & (K Units) Table 9. Global Autoimmune Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Autoimmune Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Autoimmune Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Autoimmune Drugs Price by Type (2021-2026) & (US$/Unit) Table 13. Global Autoimmune Drugs Sales by Type (2027-2032) & (K Units) Table 14. Global Autoimmune Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Autoimmune Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Autoimmune Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Autoimmune Drugs Price by Type (2027-2032) & (US$/Unit) Table 18. North America Autoimmune Drugs Sales by Type (2021-2026) & (K Units) Table 19. North America Autoimmune Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Autoimmune Drugs Sales by Type (2021-2026) & (K Units) Table 21. Europe Autoimmune Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Autoimmune Drugs Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Autoimmune Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Autoimmune Drugs Sales by Type (2021-2026) & (K Units) Table 25. Latin America Autoimmune Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Autoimmune Drugs Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Autoimmune Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Autoimmune Drugs Industry Trends Table 29. Autoimmune Drugs Industry Drivers Table 30. Autoimmune Drugs Industry Opportunities and Challenges Table 31. Autoimmune Drugs Industry Restraints Table 32. Global Autoimmune Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Autoimmune Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Autoimmune Drugs Sales by Company (2021-2026) & (K Units) Table 35. Global Autoimmune Drugs Sales Share by Company (2021-2026) Table 36. Global Autoimmune Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Autoimmune Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Autoimmune Drugs Major Company Production Sites and Headquarters Table 39. Global Autoimmune Drugs Company, Product Type & Application Table 40. Global Autoimmune Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Autoimmune Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Autoimmune Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Autoimmune Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Autoimmune Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Autoimmune Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Autoimmune Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Autoimmune Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Autoimmune Drugs Sales by Region (2027-2032) & (K Units) Table 50. Global Autoimmune Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Autoimmune Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Autoimmune Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Autoimmune Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Autoimmune Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Autoimmune Drugs Sales by Application (2021-2026) & (K Units) Table 56. Global Autoimmune Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Autoimmune Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Autoimmune Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Autoimmune Drugs Price by Application (2021-2026) & (US$/Unit) Table 60. Global Autoimmune Drugs Sales by Application (2027-2032) & (K Units) Table 61. Global Autoimmune Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Autoimmune Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Autoimmune Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Autoimmune Drugs Price by Application (2027-2032) & (US$/Unit) Table 65. North America Autoimmune Drugs Sales by Application (2021-2026) & (K Units) Table 66. North America Autoimmune Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Autoimmune Drugs Sales by Application (2021-2026) & (K Units) Table 68. Europe Autoimmune Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Autoimmune Drugs Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Autoimmune Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Autoimmune Drugs Sales by Application (2021-2026) & (K Units) Table 72. Latin America Autoimmune Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Autoimmune Drugs Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Autoimmune Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Biogen Company Information Table 76. Biogen Business Overview Table 77. Biogen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Biogen Autoimmune Drugs Product Portfolio Table 79. Biogen Recent Development Table 80. AbbVie Company Information Table 81. AbbVie Business Overview Table 82. AbbVie Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. AbbVie Autoimmune Drugs Product Portfolio Table 84. AbbVie Recent Development Table 85. Amgen Company Information Table 86. Amgen Business Overview Table 87. Amgen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Amgen Autoimmune Drugs Product Portfolio Table 89. Amgen Recent Development Table 90. Baxter Company Information Table 91. Baxter Business Overview Table 92. Baxter Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Baxter Autoimmune Drugs Product Portfolio Table 94. Baxter Recent Development Table 95. GSK Company Information Table 96. GSK Business Overview Table 97. GSK Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. GSK Autoimmune Drugs Product Portfolio Table 99. GSK Recent Development Table 100. Pfizer Company Information Table 101. Pfizer Business Overview Table 102. Pfizer Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Pfizer Autoimmune Drugs Product Portfolio Table 104. Pfizer Recent Development Table 105. Eli Lilly Company Information Table 106. Eli Lilly Business Overview Table 107. Eli Lilly Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Eli Lilly Autoimmune Drugs Product Portfolio Table 109. Eli Lilly Recent Development Table 110. Roche Company Information Table 111. Roche Business Overview Table 112. Roche Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Roche Autoimmune Drugs Product Portfolio Table 114. Roche Recent Development Table 115. Johnson & Johnson Company Information Table 116. Johnson & Johnson Business Overview Table 117. Johnson & Johnson Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Johnson & Johnson Autoimmune Drugs Product Portfolio Table 119. Johnson & Johnson Recent Development Table 120. North America Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 121. North America Autoimmune Drugs Sales by Country (2021-2026) & (K Units) Table 122. North America Autoimmune Drugs Sales Market Share by Country (2021-2026) Table 123. North America Autoimmune Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 124. North America Autoimmune Drugs Sales Market Share Forecast by Country (2027-2032) Table 125. North America Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. North America Autoimmune Drugs Market Size by Country (2021-2026) & (US$ Million) Table 127. North America Autoimmune Drugs Market Share by Country (2021-2026) Table 128. North America Autoimmune Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. North America Autoimmune Drugs Market Share Forecast by Country (2027-2032) Table 130. Europe Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 131. Europe Autoimmune Drugs Sales by Country (2021-2026) & (K Units) Table 132. Europe Autoimmune Drugs Sales Market Share by Country (2021-2026) Table 133. Europe Autoimmune Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 134. Europe Autoimmune Drugs Sales Market Share Forecast by Country (2027-2032) Table 135. Europe Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Europe Autoimmune Drugs Market Size by Country (2021-2026) & (US$ Million) Table 137. Europe Autoimmune Drugs Market Share by Country (2021-2026) Table 138. Europe Autoimmune Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Europe Autoimmune Drugs Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Autoimmune Drugs Sales by Country (2021-2026) & (K Units) Table 142. Asia-Pacific Autoimmune Drugs Sales Market Share by Country (2021-2026) Table 143. Asia-Pacific Autoimmune Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 144. Asia-Pacific Autoimmune Drugs Sales Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Autoimmune Drugs Market Size by Country (2021-2026) & (US$ Million) Table 147. Asia-Pacific Autoimmune Drugs Market Share by Country (2021-2026) Table 148. Asia-Pacific Autoimmune Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Asia-Pacific Autoimmune Drugs Market Share Forecast by Country (2027-2032) Table 150. Latin America Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 151. Latin America Autoimmune Drugs Sales by Country (2021-2026) & (K Units) Table 152. Latin America Autoimmune Drugs Sales Market Share by Country (2021-2026) Table 153. Latin America Autoimmune Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 154. Latin America Autoimmune Drugs Sales Market Share Forecast by Country (2027-2032) Table 155. Latin America Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Latin America Autoimmune Drugs Market Size by Country (2021-2026) & (US$ Million) Table 157. Latin America Autoimmune Drugs Market Share by Country (2021-2026) Table 158. Latin America Autoimmune Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Latin America Autoimmune Drugs Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Autoimmune Drugs Sales by Country (2021-2026) & (K Units) Table 162. Middle East and Africa Autoimmune Drugs Sales Market Share by Country (2021-2026) Table 163. Middle East and Africa Autoimmune Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 164. Middle East and Africa Autoimmune Drugs Sales Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Autoimmune Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Autoimmune Drugs Market Size by Country (2021-2026) & (US$ Million) Table 167. Middle East and Africa Autoimmune Drugs Market Share by Country (2021-2026) Table 168. Middle East and Africa Autoimmune Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Middle East and Africa Autoimmune Drugs Market Share Forecast by Country (2027-2032) Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Autoimmune Drugs Distributors List Table 173. Autoimmune Drugs Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Autoimmune Drugs Image Figure 2. Global Autoimmune Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Autoimmune Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Autoimmune Drugs Sales (2021-2032) & (K Units) Figure 5. Psoriasis Image Figure 6. Global Psoriasis Sales YoY Growth (2021-2032) & (K Units) Figure 7. Inflammatory Bowel Disease (IBD) Image Figure 8. Global Inflammatory Bowel Disease (IBD) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Systemic Lupus Erythematosus (SLE) Image Figure 10. Global Systemic Lupus Erythematosus (SLE) Sales YoY Growth (2021-2032) & (K Units) Figure 11. Ankylosing Spondylitis (AS) Image Figure 12. Global Ankylosing Spondylitis (AS) Sales YoY Growth (2021-2032) & (K Units) Figure 13. Rheumatoid Arthritis (RA) Image Figure 14. Global Rheumatoid Arthritis (RA) Sales YoY Growth (2021-2032) & (K Units) Figure 15. Multiple Sclerosis (MS) Image Figure 16. Global Multiple Sclerosis (MS) Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Autoimmune Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Autoimmune Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Autoimmune Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Autoimmune Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Autoimmune Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Autoimmune Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Autoimmune Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Autoimmune Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Autoimmune Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Autoimmune Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Autoimmune Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Autoimmune Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Autoimmune Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospitals Image Figure 32. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 33. Homecare Image Figure 34. Global Homecare Sales YoY Growth (2021-2032) & (K Units) Figure 35. Specialty Clinics Image Figure 36. Global Specialty Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Autoimmune Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Autoimmune Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Autoimmune Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Autoimmune Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Autoimmune Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Autoimmune Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Autoimmune Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Autoimmune Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Autoimmune Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Autoimmune Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Autoimmune Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Autoimmune Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Autoimmune Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Autoimmune Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Autoimmune Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Autoimmune Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Autoimmune Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Autoimmune Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Autoimmune Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Autoimmune Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Autoimmune Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Autoimmune Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Autoimmune Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Autoimmune Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Autoimmune Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Autoimmune Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Autoimmune Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Autoimmune Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Autoimmune Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Autoimmune Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Autoimmune Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Autoimmune Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Autoimmune Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Autoimmune Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Psoriasis
  • Inflammatory Bowel Disease (IBD)
  • Systemic Lupus Erythematosus (SLE)
  • Ankylosing Spondylitis (AS)
  • Rheumatoid Arthritis (RA)
  • Multiple Sclerosis (MS)
Applications
  • Hospitals
  • Homecare
  • Specialty Clinics
Companies covered
  • Biogen
  • AbbVie
  • Amgen
  • Baxter
  • GSK
  • Pfizer
  • Eli Lilly
  • Roche
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Autoimmune Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Autoimmune Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Autoimmune Drugs Market by Type
  6. 1.3.1 Psoriasis
  7. 1.3.2 Inflammatory Bowel Disease (IBD)
  8. 1.3.3 Systemic Lupus Erythematosus (SLE)
  9. 1.3.4 Ankylosing Spondylitis (AS)
  10. 1.3.5 Rheumatoid Arthritis (RA)
  11. 1.3.6 Multiple Sclerosis (MS)
  12. 1.4 Global Autoimmune Drugs Market Size by Type
  13. 1.4.1 Global Autoimmune Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Autoimmune Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Autoimmune Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Autoimmune Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Autoimmune Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Autoimmune Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Autoimmune Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Autoimmune Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Autoimmune Drugs Industry Trends
  2. 2.2 Autoimmune Drugs Industry Drivers
  3. 2.3 Autoimmune Drugs Industry Opportunities and Challenges
  4. 2.4 Autoimmune Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Autoimmune Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Autoimmune Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Autoimmune Drugs Price (2021-2026)
  4. 3.4 Global Autoimmune Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Autoimmune Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Autoimmune Drugs Company, Product Type & Application
  7. 3.7 Global Autoimmune Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Autoimmune Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Autoimmune Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Autoimmune Drugs Tier 1, Tier 2, and Tier 3
4 Autoimmune Drugs Regional Status and Outlook
  1. 4.1 Global Autoimmune Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Autoimmune Drugs Historic Market Size by Region
  3. 4.2.1 Global Autoimmune Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Autoimmune Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Autoimmune Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Autoimmune Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Autoimmune Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Autoimmune Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Autoimmune Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Autoimmune Drugs by Application
  1. 5.1 Autoimmune Drugs Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Homecare
  4. 5.1.3 Specialty Clinics
  5. 5.2 Global Autoimmune Drugs Market Size by Application
  6. 5.2.1 Global Autoimmune Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Autoimmune Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Autoimmune Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Autoimmune Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Autoimmune Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Autoimmune Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Autoimmune Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Autoimmune Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biogen
  2. 6.1.1 Biogen Company Information
  3. 6.1.2 Biogen Business Overview
  4. 6.1.3 Biogen Autoimmune Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biogen Autoimmune Drugs Product Portfolio
  6. 6.1.5 Biogen Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Autoimmune Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Autoimmune Drugs Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Autoimmune Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Autoimmune Drugs Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Baxter
  20. 6.4.1 Baxter Company Information
  21. 6.4.2 Baxter Business Overview
  22. 6.4.3 Baxter Autoimmune Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter Autoimmune Drugs Product Portfolio
  24. 6.4.5 Baxter Recent Developments
  25. 6.5 GSK
  26. 6.5.1 GSK Company Information
  27. 6.5.2 GSK Business Overview
  28. 6.5.3 GSK Autoimmune Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GSK Autoimmune Drugs Product Portfolio
  30. 6.5.5 GSK Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Autoimmune Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Autoimmune Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Eli Lilly
  38. 6.7.1 Eli Lilly Company Information
  39. 6.7.2 Eli Lilly Business Overview
  40. 6.7.3 Eli Lilly Autoimmune Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly Autoimmune Drugs Product Portfolio
  42. 6.7.5 Eli Lilly Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Autoimmune Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roche Autoimmune Drugs Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Autoimmune Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Autoimmune Drugs Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Autoimmune Drugs Sales by Country
  2. 7.1.1 North America Autoimmune Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Autoimmune Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Autoimmune Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Autoimmune Drugs Market Size by Country
  6. 7.2.1 North America Autoimmune Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Autoimmune Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Autoimmune Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Autoimmune Drugs Sales by Country
  2. 8.1.1 Europe Autoimmune Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Autoimmune Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Autoimmune Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Autoimmune Drugs Market Size by Country
  6. 8.2.1 Europe Autoimmune Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Autoimmune Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Autoimmune Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Autoimmune Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Autoimmune Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Autoimmune Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Autoimmune Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Autoimmune Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Autoimmune Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Autoimmune Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Autoimmune Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Autoimmune Drugs Sales by Country
  2. 10.1.1 South America Autoimmune Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Autoimmune Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Autoimmune Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Autoimmune Drugs Market Size by Country
  6. 10.2.1 South America Autoimmune Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Autoimmune Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Autoimmune Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Autoimmune Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Autoimmune Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Autoimmune Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Autoimmune Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Autoimmune Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Autoimmune Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Autoimmune Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Autoimmune Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Autoimmune Drugs Value Chain Analysis
  2. 12.1.1 Autoimmune Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Autoimmune Drugs Production Mode & Process
  7. 12.2 Autoimmune Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Autoimmune Drugs Distributors
  10. 12.2.3 Autoimmune Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst